EP3773747A4 - Utilisation d'exosomes pour l'administration ciblée d'agents thérapeutiques - Google Patents
Utilisation d'exosomes pour l'administration ciblée d'agents thérapeutiques Download PDFInfo
- Publication number
- EP3773747A4 EP3773747A4 EP19776678.5A EP19776678A EP3773747A4 EP 3773747 A4 EP3773747 A4 EP 3773747A4 EP 19776678 A EP19776678 A EP 19776678A EP 3773747 A4 EP3773747 A4 EP 3773747A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- exosomes
- therapeutic agents
- targeted delivery
- targeted
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862649057P | 2018-03-28 | 2018-03-28 | |
PCT/US2019/024603 WO2019191444A1 (fr) | 2018-03-28 | 2019-03-28 | Utilisation d'exosomes pour l'administration ciblée d'agents thérapeutiques |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3773747A1 EP3773747A1 (fr) | 2021-02-17 |
EP3773747A4 true EP3773747A4 (fr) | 2022-02-23 |
Family
ID=68060505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19776678.5A Pending EP3773747A4 (fr) | 2018-03-28 | 2019-03-28 | Utilisation d'exosomes pour l'administration ciblée d'agents thérapeutiques |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP3773747A4 (fr) |
JP (1) | JP2021519296A (fr) |
KR (1) | KR20200136978A (fr) |
CN (1) | CN112533643A (fr) |
AU (1) | AU2019243179A1 (fr) |
CA (1) | CA3095136A1 (fr) |
WO (1) | WO2019191444A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201900007785A1 (it) * | 2019-05-31 | 2020-12-01 | Univ Degli Studi Milano | Vescicole extracellulari per veicolare farmaci terapeutici o diagnostici |
CN115297850A (zh) * | 2019-12-05 | 2022-11-04 | 得克萨斯州大学***董事会 | 用于肝纤维化和其他与纤维化相关的疾病的基于外排体的治疗 |
WO2021119552A1 (fr) * | 2019-12-13 | 2021-06-17 | Lawrence Livermore National Security, Llc | Compositions de vésicule à nanotubes et utilisations associées |
CN117860902B (zh) * | 2021-11-17 | 2024-07-16 | 中国人民解放军空军军医大学 | 一种***癌分子靶向***及其构建方法和应用 |
CN114774471A (zh) * | 2022-05-10 | 2022-07-22 | 厦门星际诺康细胞科技有限公司 | 一种呈现il27稳转细胞及其构建方法、呈现il27工程化外泌体及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015085096A1 (fr) * | 2013-12-04 | 2015-06-11 | Board Of Regents, The University Of Texas System | Analyse d'adn génomique, d'arn et de protéines dans des exosomes pour le diagnostic et la thérapie |
WO2016201323A1 (fr) * | 2015-06-10 | 2016-12-15 | Board Of Regents, The University Of Texas System | Utilisation d'exosomes pour le traitement de maladies |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7473678B2 (en) * | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
US9085778B2 (en) * | 2006-05-03 | 2015-07-21 | VL27, Inc. | Exosome transfer of nucleic acids to cells |
GB201121069D0 (en) * | 2011-12-07 | 2012-01-18 | Isis Innovation | Delivery system |
CN105051192B (zh) * | 2012-11-13 | 2020-04-17 | 科迪艾克生物科学公司 | 治疗剂的递送 |
BR112015002626A2 (pt) * | 2012-11-29 | 2017-09-26 | Yeda Res & Dev | métodos para prevenção de metástases tumorais, tratamento e prognostico do câncer e identificação dos agentes que são inibidores da metástase putativa |
US20190008902A1 (en) * | 2015-12-30 | 2019-01-10 | The Regents Of The University Of California | Methods for enhanced production and isolation of cell-derived vesicles |
TWI601741B (zh) * | 2016-07-11 | 2017-10-11 | 財團法人國家衛生研究院 | 利用***素受體ep4-拮抗劑誘導幹細胞製造含有高囊泡含物之外泌體囊泡的方法及其應用 |
-
2019
- 2019-03-28 CA CA3095136A patent/CA3095136A1/fr active Pending
- 2019-03-28 KR KR1020207030993A patent/KR20200136978A/ko unknown
- 2019-03-28 CN CN201980034058.9A patent/CN112533643A/zh active Pending
- 2019-03-28 EP EP19776678.5A patent/EP3773747A4/fr active Pending
- 2019-03-28 JP JP2020551798A patent/JP2021519296A/ja active Pending
- 2019-03-28 WO PCT/US2019/024603 patent/WO2019191444A1/fr unknown
- 2019-03-28 AU AU2019243179A patent/AU2019243179A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015085096A1 (fr) * | 2013-12-04 | 2015-06-11 | Board Of Regents, The University Of Texas System | Analyse d'adn génomique, d'arn et de protéines dans des exosomes pour le diagnostic et la thérapie |
WO2016201323A1 (fr) * | 2015-06-10 | 2016-12-15 | Board Of Regents, The University Of Texas System | Utilisation d'exosomes pour le traitement de maladies |
Non-Patent Citations (2)
Title |
---|
See also references of WO2019191444A1 * |
SHIN-ICHIRO OHNO ET AL: "Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells", MOLECULAR THERAPY, vol. 21, no. 1, 1 January 2013 (2013-01-01), US, pages 185 - 191, XP055501314, ISSN: 1525-0016, DOI: 10.1038/mt.2012.180 * |
Also Published As
Publication number | Publication date |
---|---|
KR20200136978A (ko) | 2020-12-08 |
WO2019191444A1 (fr) | 2019-10-03 |
CN112533643A (zh) | 2021-03-19 |
CA3095136A1 (fr) | 2019-10-03 |
EP3773747A1 (fr) | 2021-02-17 |
AU2019243179A1 (en) | 2020-11-12 |
JP2021519296A (ja) | 2021-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3548005A4 (fr) | Exosomes destinés à l'administration d'agents thérapeutiques | |
EP3840730A4 (fr) | Compositions pour l'administration d'agents thérapeutiques et leurs méthodes d'utilisation et leurs procédés de préparation | |
IL268999B (en) | Compounds and preparations for intracellular administration of medicinal agents | |
EP3386484A4 (fr) | Compositions et procédés permettant d'administrer des agents thérapeutiques | |
EP3773747A4 (fr) | Utilisation d'exosomes pour l'administration ciblée d'agents thérapeutiques | |
EP3471672B8 (fr) | Dispositif d'injection destiné à l'administration sous-rétinienne d'un agent thérapeutique | |
EP3749344A4 (fr) | Procédés d'utilisation thérapeutique d'exosomes et d'arn y | |
EP3817747A4 (fr) | Administration ciblée d'agents thérapeutiques à des adipocytes humains | |
EP3512554A4 (fr) | Compositions plaquettaires et procédés pour l'administration d'agents thérapeutiques | |
EP3735463A4 (fr) | Agent thérapeutique induisant une cytotoxicité | |
IL251349A0 (en) | Routing of melanocytes to deliver medical or diagnostic agents using nanocage proteins | |
EP4021369A4 (fr) | Dispositifs médicaux pour l'administration continue d'agents thérapeutiques | |
EP3927328A4 (fr) | Agent thérapeutique inhalable | |
EP3525772A4 (fr) | Formulations destinées à l'administration entérique d'agents thérapeutiques | |
EP3777893A4 (fr) | Utilisation d'un composé de bis-iminobiotine pour des fins d'administration de médicament | |
IL275690A (en) | Nanoparticles for targeted delivery of therapeutic polypeptides | |
EP3773492A4 (fr) | Ciblage thérapeutique d'oncogènes à l'aide d'exosomes | |
EP3836866A4 (fr) | Systèmes d'administration entérique d'agents thérapeutiques | |
EP3171858A4 (fr) | Procédés et compositions pour l'administration ciblée d'agents thérapeutiques | |
EP3651741A4 (fr) | Compositions et méthodes destinées à l'administration ciblée d'espèces thérapeutiques et/ou diagnostiques | |
IL284411A (en) | Targeted transport of drug molecules | |
EP3886913A4 (fr) | Administration ciblée améliorée d'agents thérapeutiques | |
EP3362096A4 (fr) | Composition de traitement ophtalmique et véhicule pour l'administration de substances pharmaceutiques ou d'agents thérapeutiques | |
EP3781194A4 (fr) | Compositions et méthodes pour l'administration sélective d'agents thérapeutiques et/ou d'imagerie | |
EP3808356A4 (fr) | Agent thérapeutique tissulaire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200930 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220124 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 15/113 20100101ALI20220118BHEP Ipc: C12N 15/87 20060101ALI20220118BHEP Ipc: A61K 48/00 20060101AFI20220118BHEP |